Cargando…

Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys

BACKGROUND: The initial envelope (Env)-specific antibody response in acutely HIV-1-infected individuals and simian immunodeficiency virus (SIV)-infected rhesus monkeys (RMs) is dominated by non-neutralizing antibodies targeting Env gp41. In contrast, natural primate SIV hosts, such as African green...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Quang N., Martinez, David R., Himes, Jonathon E., Whitney Edwards, R., Han, Qifeng, Kumar, Amit, Mangan, Riley, Nicely, Nathan I., Xie, Guanhua, Vandergrift, Nathan, Shen, Xiaoying, Pollara, Justin, Permar, Sallie R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845189/ https://www.ncbi.nlm.nih.gov/pubmed/29523166 http://dx.doi.org/10.1186/s12977-018-0406-5

Ejemplares similares

The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells
por: Jeffries, Thomas L, et al.
Publicado: (2015)

Polyclonal HIV envelope-specific breast milk antibodies limit founder SHIV acquisition and cell-associated virus loads in infant rhesus monkeys.
por: Himes, Jonathon E., et al.
Publicado: (2018)

Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α(4)β(7)
por: Lertjuthaporn, Sakaorat, et al.
Publicado: (2018)

MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
por: Ruprecht, Claudia R., et al.
Publicado: (2011)

Strong SIV gp120-specific IgG/IgA responses in milk of African green monkeys may contribute to the rarity of postnatal transmission in this species
por: Amos, JD, et al.
Publicado: (2012)

Antibodies to the CD4-binding site of HIV-1 gp120 suppress gp120-specific CD4 T cell response while enhancing antibody response
por: Visciano, Maria Luisa, et al.
Publicado: (2008)

Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virus
por: Zhang, Ruijun, et al.
Publicado: (2016)

Differential glycosylation of envelope gp120 affects reactivity with HIV-1 specific antibodies
por: Czernekova, Lydie, et al.
Publicado: (2014)

The Role of Maternal HIV Envelope-Specific Antibodies and Mother-to-Child Transmission Risk
por: Douglas, Ayooluwa O., et al.
Publicado: (2017)

The Impact of the Gut Microbiota on Humoral Immunity to Pathogens and Vaccination in Early Infancy
por: Nguyen, Quang N., et al.
Publicado: (2016)

Eliciting neutralizing antibodies with gp120 outer domain
por: Qin, Y, et al.
Publicado: (2012)

Role of anti-CD4-binding site antibodies in modulating gp120-specific CD4 T cell and antibody responses
por: Visciano, ML, et al.
Publicado: (2006)

DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial
por: Rouphael, Nadine G., et al.
Publicado: (2019)

Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection
por: Raska, Milan, et al.
Publicado: (2014)

E-DNA IM or ID delivery prime enhances antibody and T cell responses following recombinant gp120 env boost
por: Hutnick, NA, et al.
Publicado: (2012)

116. Role of Maternal Antibodies in Protection Against Postnatal Cytomegalovirus Acquisition
por: Saccoccio, Frances, et al.
Publicado: (2018)

Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies
por: Rusert, Peter, et al.
Publicado: (2011)

Engineered gp120 immunogens that elicit VRC01-like antibodies by vaccination
por: Mata-Fink, J, et al.
Publicado: (2012)

Restricted isotype, distinct variable gene usage, and high rate of gp120-specificity of HIV-1 Envelope-specific B cells in colostrum compared to those in blood of HIV-1-infected, lactating African women
por: Sacha, C.R., et al.
Publicado: (2014)

A Twin-Cysteine Motif in the V2 Region of gp120 Is Associated with SIV Envelope Trimer Stabilization
por: Bohl, Christopher, et al.
Publicado: (2013)

Evaluation of global HIV/SIV envelope gp120 RNA structure and evolution within and among infected hosts
por: Rife Magalis, Brittany, et al.
Publicado: (2018)

Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
por: Zolla-Pazner, Susan, et al.
Publicado: (2014)

The C5 region of HIV-1 gp120 binds specific
por: Dalgleish, A, et al.
Publicado: (2006)

ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission
por: Semmes, Eleanor C., et al.
Publicado: (2023)

Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4
por: Welles, Hugh C., et al.
Publicado: (2022)

Early Post-Vaccination Gene Signatures Correlate With the Magnitude and Function of Vaccine-Induced HIV Envelope-Specific Plasma Antibodies in Infant Rhesus Macaques
por: Vijayan, K. K. Vidya, et al.
Publicado: (2022)

Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations
por: Akapirat, Siriwat, et al.
Publicado: (2018)

Trimeric gp120-specific bovine monoclonal antibodies require cysteine and aromatic residues in CDRH3 for high affinity binding to HIV Env
por: Heydarchi, Behnaz, et al.
Publicado: (2016)

Vaccine with bacterium‐like particles displaying HIV‐1 gp120 trimer elicits specific mucosal responses and neutralizing antibodies in rhesus macaques
por: Wang, Huaiyu, et al.
Publicado: (2022)

Identification and Characterization of a Broadly Cross-Reactive HIV-1 Human Monoclonal Antibody That Binds to Both gp120 and gp41
por: Zhang, Mei-Yun, et al.
Publicado: (2012)

P04-48. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after gp120 protein vaccination or chronic HIV-1 infection
por: Bonsignori, M, et al.
Publicado: (2009)

OAO5-04. Gp96-Ig-SIV vaccines induce predominant immune responses at mucosal sites
por: Strbo, N, et al.
Publicado: (2009)

Modeling the Effects of Morphine-Altered Virus Specific Antibody Responses on HIV/SIV Dynamics
por: Mutua, Jones M., et al.
Publicado: (2019)

Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies
por: Pedreño-Lopez, Nuria, et al.
Publicado: (2020)

Effect of site-specific de-glycosylation on HIV gp120-specific CD4 T cell responses
por: Li, Hualin, et al.
Publicado: (2006)

P04-01. Simultaneous enumeration of HIV-1 gp41 Env-specific IgG and IgM antibody-secreting cells with a multiplex B-cell fluorospot assay
por: Bonsignori, M, et al.
Publicado: (2009)

Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape
por: Wibmer, Constantinos Kurt, et al.
Publicado: (2017)

Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
por: Strokappe, Nika M., et al.
Publicado: (2019)

Increased infectivity in human cells and resistance to antibody-mediated neutralization by truncation of the SIV gp41 cytoplasmic tail
por: Kuwata, Takeo, et al.
Publicado: (2013)

Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-120 interface
por: Huang, Jinghe, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3f7s0t20crlknfgak487sm73tp